Signed in · PRO

Guidance history, every release

Humana (HUM) · 8 releases, Oct 30, 2024 to Jul 29, 2026 · rows are metrics, columns are releases

Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing

Metric	Oct 30, 2024 FY24 Q3	Feb 11, 2025 FY24 Q4	Apr 30, 2025 FY25 Q1	Jul 30, 2025 FY25 Q2	Nov 5, 2025 FY25 Q3	Feb 11, 2026 FY25 Q4	Apr 29, 2026 FY26 Q1	Jul 29, 2026 FY26 Q2
For FY2027
Medicaid footprint expansion (Georgia and Texas)	—	—	—	—	—	New“expected to launch in 2027”	—	—
For FY2026
1Q26 Adjusted EPS (percent of full year 2026 Adjusted EPS)	—	—	—	—	—	—	New“approximately 110 percent to 115 percent”	—
Adjusted (non-GAAP) EPS	—	—	—	—	—	—	—	New“at least $9.00”
Adjusted EPS	—	—	—	—	—	New“at least $9.00”	—	Reiterated“at least $9.00”
Diluted earnings per share (EPS) - Adjusted (non-GAAP)	—	—	—	—	—	New“at least $9.00”	Reiterated“at least $9.00”	Reiterated“at least $9.00”
Diluted earnings per share (EPS) - GAAP	—	—	—	—	—	New“at least $8.89”	Lowered“at least $8.36”	Lowered“at least $6.52”
GAAP EPS	—	—	—	—	—	—	—	New“at least $6.52”
GAAP EPS	—	—	—	—	—	New“at least $8.89”	Lowered“at least $8.36”	—
(FY) 2026 Insurance segment benefit ratio	—	—	—	—	—	—	—	New“92.75 percent, plus or minus 25 basis points”
1Q26 Insurance segment GAAP benefit ratio	—	—	—	—	—	—	New“just under 90 percent”	—
GAAP	—	—	—	—	—	New“at least $8.89”	—	—
Individual Medicare Advantage (MA) membership growth	—	—	—	—	—	—	New“approximately 25 percent”	Reiterated“approximately 25 percent”
Individual Medicare Advantage membership growth	—	—	—	—	—	New“approximately 25 percent”	—	—
Insurance segment benefit ratio	—	—	—	—	—	—	New“92.75 percent, plus or minus 25 basis points”	—
For FY2025
Consolidated revenues	—	—	—	New“at least $128 billion”	—	—	—	—
Total Revenues - CenterWell segment	—	—	—	New“GAAP: at least $21.5 billion”	—	—	—	—
Total Revenues - Insurance segment	—	—	—	New“GAAP: at least $123 billion”	—	—	—	—
Total Revenues CenterWell segment - GAAP	—	New“$20.5 billion to $21.5 billion”	Reiterated“$20.5 billion to $21.5 billion”	Reiterated“$20.5 billion to $21.5 billion”	Raised“at least $21.5 billion”	—	—	—
Total Revenues Consolidated - GAAP	—	New“$126 billion to $128 billion”	Reiterated“$126 billion to $128 billion”	Raised“at least $128 billion”	Reiterated“at least $128 billion”	—	—	—
Total Revenues Insurance segment - GAAP	—	New“$121 billion to $123 billion”	Reiterated“$121 billion to $123 billion”	—	Raised“at least $123 billion”	—	—	—
Adjusted (non-GAAP) EPS	—	—	—	New“approximately $17.00”	—	—	—	—
Adjusted (non-GAAP) EPS	—	New“approximately $16.25”	—	—	—	—	—	—
Adjusted EPS	—	New“approximately $16.25”	—	—	—	—	—	—
Adjusted FY 2025 EPS	—	—	New“approximately $16.25”	—	Raised“approximately $17.00”	—	—	—
Adjusted FY 2025 EPS	—	New“at least in line with 2024 results”	—	—	—	—	—	—
Diluted earnings per common share - GAAP	—	New“approximately $15.88”	—	—	—	—	—	—
Diluted earnings per common share (EPS) GAAP	—	—	New“approximately $14.68 (previously approximately $15.88)”	—	—	—	—	—
Diluted earnings per share (Adjusted non-GAAP)	—	New“approximately $16.25”	—	—	—	—	—	—
Diluted earnings per share (EPS) - Adjusted (non-GAAP)	—	—	New“approximately $16.25”	Raised“approximately $17.00”	Reiterated“approximately $17.00”	—	—	—
Diluted earnings per share (EPS) - GAAP	—	—	New“approximately $14.68”	Lowered“approximately $13.77”	Lowered“approximately $12.26”	—	—	—
Diluted EPS - GAAP	—	—	—	—	New“approximately $12.26”	—	—	—
Diluted EPS - Non-GAAP	—	—	—	—	New“approximately $17.00”	—	—	—
GAAP EPS	—	New“approximately $15.88”	—	Lowered“approximately $13.77”	Lowered“approximately $12.26”	—	—	—
GAAP EPS	—	New“approximately $15.88”	Lowered“approximately $14.68”	—	—	—	—	—
Weighted Avg. Share Count for Diluted EPS	—	New“approximately 121.5 million”	Reiterated“approximately 121.5 million”	Lowered“approximately 121 million”	Reiterated“approximately 121 million”	—	—	—
Benefit Ratio Insurance segment - GAAP	—	New“90.1% to 90.5%”	—	—	—	—	—	—
Capital expenditures	—	New“approximately $650 million”	Reiterated“approximately $650 million”	Reiterated“approximately $650 million”	Reiterated“approximately $650 million”	—	—	—
Cash flows from operations	—	—	—	New“GAAP: $2.4 billion to $2.9 billion”	—	—	—	—
Cash flows from operations - GAAP	—	New“$2.4 billion to $2.9 billion”	Reiterated“$2.4 billion to $2.9 billion”	—	Reiterated“$2.4 billion to $2.9 billion”	—	—	—
CenterWell Primary Care FY 2025 net patient growth	—	—	—	New“50,000 to 70,000”	—	—	—	—
CenterWell segment income from operations - GAAP	—	New“$1.0 billion to $1.5 billion”	Reiterated“$1.0 billion to $1.5 billion”	Narrowed“GAAP: $1.1 billion to $1.5 billion”	Reiterated“$1.1 billion to $1.5 billion”	—	—	—
CenterWell segment income from operations - Non-GAAP	—	New“$1.2 billion to $1.7 billion”	Reiterated“$1.2 billion to $1.7 billion”	Narrowed“Non-GAAP: $1.3 billion to $1.7 billion”	Reiterated“$1.3 billion to $1.7 billion”	—	—	—
Change in year-end medical membership - Group Medicare Advantage	—	—	New“Relatively flat”	Reiterated“Relatively flat”	Reiterated“Relatively flat”	—	—	—
Change in year-end medical membership - Individual Medicare Advantage	—	—	New“Decline of approximately 550,000”	Raised“Decline of 'up to 500,000'”	Raised“Decline of approximately 425,000”	—	—	—
Change in year-end medical membership - Medicare stand-alone PDP	—	—	New“Growth of approximately 200,000”	Reiterated“Growth of approximately 200,000”	Reiterated“Growth of approximately 200,000”	—	—	—
Change in year-end medical membership - State-based contracts	—	—	New“Growth within 175,000 to 250,000 range”	Reiterated“Growth within 175,000 to 250,000 range”	Lowered“Growth of approximately 160,000”	—	—	—
Change in year-end medical membership from prior year-end: Group Medicare Advantage	—	New“Relatively flat”	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: Individual Medicare Advantage	—	New“Decline of approximately 550,000”	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: Medicare stand-alone PDP	—	New“Growth of approximately 200,000”	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: State-based contracts	—	New“Growth within 175,000 to 250,000 range”	—	—	—	—	—	—
Effective Tax Rate	—	—	—	New“GAAP: approximately 25.0%”	—	—	—	—
Effective Tax Rate - GAAP	—	New“approximately 25.0%”	Reiterated“approximately 25.0%”	—	Lowered“approximately 20.0%”	—	—	—
Effective Tax Rate - Non-GAAP	—	—	—	—	New“approximately 25.0%”	—	—	—
Individual Medicare Advantage annual membership decline	—	—	New“approximately 550,000”	—	—	—	—	—
Individual Medicare Advantage annual membership decline	—	New“approximately 550,000, or approximately 10 percent”	—	—	—	—	—	—
Individual Medicare Advantage membership (decline)	—	—	—	New“up to 500,000 members”	Lowered“approximately 425,000 members”	—	—	—
Insurance segment benefit ratio	—	—	New“90.1 percent to 90.5 percent”	Reiterated“90.1 percent to 90.5 percent”	Reiterated“90.1 percent to 90.5 percent”	—	—	—
Insurance segment income from operations - GAAP	—	—	—	—	New“$1.6 billion to $2.0 billion”	—	—	—
Operating Cost Ratio - Consolidated GAAP	—	New“11.3% to 11.7%”	Reiterated“11.3% to 11.7%”	Reiterated“11.3% to 11.7%”	Raised“11.6% to 12.1%”	—	—	—
Operating Cost Ratio - Consolidated Non-GAAP	—	—	—	—	New“11.3% to 11.7%”	—	—	—
Segment Results - Insurance segment income from operations GAAP	—	—	New“$1.5 billion to $2.0 billion”	Narrowed“$1.6 billion to $2.0 billion”	—	—	—	—
Segment Results: Insurance segment income from operations	—	New“GAAP: $1.5 billion to $2.0 billion”	—	—	—	—	—	—
For FY2024
Total Revenues, CenterWell segment, GAAP	New“approximately $19 billion”	—	—	—	—	—	—	—
Total Revenues, Consolidated, GAAP	New“approximately $116 billion”	—	—	—	—	—	—	—
Total Revenues, Insurance segment, GAAP	New“approximately $112 billion”	—	—	—	—	—	—	—
Total Revenues: CenterWell segment	New“no change”	—	—	—	—	—	—	—
Total Revenues: Consolidated	New“no change”	—	—	—	—	—	—	—
Diluted earnings per common share (GAAP)	New“at least $12.89”	—	—	—	—	—	—	—
Diluted earnings per share (Adjusted non-GAAP)	New“at least $16.00”	—	—	—	—	—	—	—
EPS, Adjusted basis	New“at least $16.00”	—	—	—	—	—	—	—
EPS, GAAP basis	New“at least $12.89”	—	—	—	—	—	—	—
Weighted Avg. Share Count for Diluted EPS	New“approximately 121 million”	—	—	—	—	—	—	—
Benefit Ratio, Insurance segment, GAAP	New“approximately 90%”	—	—	—	—	—	—	—
Benefit Ratio: Insurance segment	New“no change”	—	—	—	—	—	—	—
Capital expenditures, GAAP	New“approximately $600 million”	—	—	—	—	—	—	—
Cash flows from operations, GAAP	New“approximately $2.75 billion”	—	—	—	—	—	—	—
CenterWell segment income from operations, Non-GAAP	New“approximately $1.4 billion”	—	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: Group Medicare Advantage	New“Growth of approximately 35,000”	—	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: Individual Medicare Advantage	New“Growth of approximately 265,000”	—	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: Medicare stand-alone PDP	New“no change”	—	—	—	—	—	—	—
Change in year-end medical membership from prior year-end: State-based contracts	New“Growth of approximately 200,000”	—	—	—	—	—	—	—
Change in year-end medical membership, Medicare stand-alone PDP	New“Decline of approximately 600,000”	—	—	—	—	—	—	—
Effective Tax Rate, GAAP	New“approximately 25.2%”	—	—	—	—	—	—	—
Effective Tax Rate, Non-GAAP	New“approximately 25.0%”	—	—	—	—	—	—	—
Individual Medicare Advantage annual membership growth	New“approximately 265,000, or approximately 5 percent”	—	—	—	—	—	—	—
Insurance segment income from operations, GAAP	New“approximately $1.1 billion”	—	—	—	—	—	—	—
Insurance segment income from operations, Non-GAAP	New“approximately $1.2 billion”	—	—	—	—	—	—	—
Operating Cost Ratio, Consolidated, GAAP	New“approximately 11.4%”	—	—	—	—	—	—	—
Operating Cost Ratio: Consolidated	New“no change”	—	—	—	—	—	—	—
Segment Results: Insurance segment income from operations	New“no change”	—	—	—	—	—	—	—

Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.